Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Legislation
    • Boards and Committees
    • Quality Management System
    • Contact Us
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Guidelines
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Verification Services
  • Covid-19
    • News & Updates
    • COVID-19 Drugs Availability
Home > COVID-19

COVID-19

Last Updated on December 9, 2021

Categories

  • Advertisements
  • Alternative Medicines
  • Central Licensing Board
  • Clinical Trials
  • COVID-19
  • Drugs
  • Enlistment Evaluation Committee
  • Events
  • General
  • Legislation
  • Licensing and Inspections
  • Medical Devices
  • Medical Devices Board
  • Meeting Minutes
  • News & Updates
  • Pharmacovigilance
  • Press Releases
  • Publications
  • Recall Alerts
  • Registration Board
  • Regulatory Updates
  • Safety Alerts
  • SROs
  • Tenders
  • Uncategorized

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: (+92) 51-9107313
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem